Figure 2. FLE treatment combined with low-dose isotretinoin
A) A 20 year old male patient presenting with baseline acne severity of IGA 4, previously undergoing topical and tetracycline therapy without effect, now wishing fast response before summertime. The patient was started in isotretinoin combined with FLE treatment.B) A 18 year old male patient presenting with baseline acne severity of IGA 3. The patient was previously treated with topical treatment, tetracycline without effect, and discontinued isotretinoin due to elevated levels of CPK, and thereby not eligible to standard dose of isotretinoin. The patient was started in low-dose isotretinoin combined with FLE treatment. C) A 20 year old female patient presenting with baseline acne severity of IGA 4. The patient was previously started on standard dose of isotretinoin, which was discontinued due to non-tolerated initial worsening of her acne. Not being eligible to standard doses of isotretinoin the patient was started on low-dose isotretinoin and OCP combined with FLE treatment.D) A 18 year old male patient presenting with baseline acne severity of IGA 3. The patient was previously treated with topical treatment, tetracycline without effect, and discontinued isotretinoin due to elevated levels of CPK and transaminase, and thereby not eligible to standard dose of isotretinoin. The patient was started in low-dose isotretinoin combined with FLE treatment. Appearance of the skin as presented at each evaluation; baseline (upper row), week 6 (second row from top), week 12 (third row from top), week 33 (fourth row from top), and week 52 (bottom row).